“…We are interested in devising synthetic strategies for heterocyclic ring systems containing the N-sulfonyl-and N-sulfonylamino moiety, which have shown significant biological activity as novel antiviral and antimicrobial agents (Azzam et al, 2017(Azzam et al, , 2020Elgemeie et al, 2017Elgemeie et al, , 2019Zhu et al, 2013). In addition, some of our recently published N-arylsulfonylpyrazoles (Elgemeie & Hanfy, 1999;Elgemeie et al, 1998Elgemeie et al, , 2002Elgemeie et al, , 2013 have been shown to be active as inhibitors of cathepsin B16 enzyme and NS2B-NS3 virus (Sidique et al, 2009;Myers et al, 2007).…”